RNAZ · ISSUER CIK 1829635
Transcode Therapeutics, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 1 Transcode Therapeutics, Inc. insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗1 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Aug 5, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 202616:05 | Aug 3, 2026 | RNAZ | 10% Owner · +1 joint | C · Convert | — | +13,834,441 | 14,134,481 | +4611% | — |